Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, Keith D., Bowlus, Christopher L., Boyer, James, Levy, Cynthia, Mayo, Marlyn·2019·Hepatology

DOI 10.1002/hep.30145

Cited by (924)

Items 101–200 of 924

Diagnosis and treatment of primary biliary cholangitis
Alena Laschtowitz, Rozanne C. de Veer, Adriaan J Van der Meer, Christoph Schramm · 2020 · United European Gastroenterology Journal
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Jones, David E.J., Beuers, Ulrich, Bonder, Alan, Carbone, Marco, Culver, Emma, Dyson, Jessica, Gish, Robert G., Hansen, Bettina E., Hirschfield, Gideon, Jones, Rebecca et al. · 2024 · Hepatology
Obeticholic acid in primary biliary cholangitis
Vignan Manne, Kris V. Kowdley · 2019 · Current Opinion in Gastroenterology
Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis
Mayo, Marlyn J., Vierling, John M., Bowlus, Christopher L., Levy, Cynthia, Hirschfield, Gideon M., Neff, Guy W., Galambos, Michael R., Gordon, Stuart C., Borg, Brian B., Harrison, Stephen A. et al. · 2024 · Alimentary Pharmacology & Therapeutics
Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study
Chunyan Wang, Ya Deng, Ping Li, Sujun Zheng, Guofeng Chen, Guangde Zhou, Jing Xu, Yanping Chen, Zheng Wang, Xueyuan Jin et al. · 2021 · Hepatology
Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges
Chengmei He, Yanlei Yang, Kunyu Zheng, Yiran Chen, Suying Liu, Yongzhe Li, Qin Han, Robert Chunhua Zhao, Li Wang, Fengchun Zhang · 2021 · Therapeutic Advances in Chronic Disease
Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives
Romelia Barba Bernal, Bryan W. Ferrigno, Esli Medina Morales, Cristina M. Castro, Daniela Goyes, Hirsh D. Trivedi, Vilas R. Patwardhan, Alan Bonder · 2023 · The Turkish Journal of Gastroenterology
Single cell sequencing analysis identifies genetics-modulated ORMDL3+ cholangiocytes having higher metabolic effects on primary biliary cholangitis
Bingyu Xiang, Chunyu Deng, Fei Qiu, Jingjing Li, Shanshan Li, Huifang Zhang, Xiuli Lin, Yukuan Huang, Yijun Zhou, Jianzhong Su et al. · 2021 · Journal of Nanobiotechnology
Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver Cirrhosis
Freya Wellhöner, Nico Döscher, Franziska Woelfl, Marius Vital, Iris Plumeier, Silke Kahl, Andrej Potthoff, Michael Peter Manns, Dietmar Helmut Pieper, Markus Cornberg et al. · 2021 · Hepatology
Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up
Juan Antonio Sorda, Esteban González Ballerga, Fernando Javier Barreyro, Alejandra Avagnina, Pilar Carballo, Andrea Páes de Lima, Jorge R Daruich · 2021 · Alimentary Pharmacology & Therapeutics
Primary biliary cholangitis: Personalizing second-line therapies
Cynthia Levy, Christopher L. Bowlus · 2024 · Hepatology
Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives
Erica Nicola Lynch, Claudia Campani, Tommaso Innocenti, Gabriele Dragoni, Maria Rosa Biagini, Paolo Forte, Andrea Galli · 2022 · World Journal of Hepatology
Emperipolesis mediated by CD8 + T cells correlates with biliary epithelia cell injury in primary biliary cholangitis
Suxian Zhao, Wen‐cong Li, Na Fu, Guangde Zhou, Shu‐hong Liu, Lina Jiang, Yuguo Zhang, Rongqi Wang, Yuemin Nan, Jingmin Zhao · 2019 · Journal of Cellular and Molecular Medicine
Treatment response to ursodeoxycholic acid in primary biliary cholangitis: A systematic review and meta-analysis.
J. Gazda, Sylvia Dražilová, Matej Gazda, M. Janíčko, Tomas Koky, Marian Macej, M. Carbone, P. Jarčuška · 2022 · Digestive and Liver Disease
Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals
Cheng Han Ng, Ansel Shao Pin Tang, Jieling Xiao, Zhen Yu Wong, Jie Ning Yong, Clarissa Elysia Fu, Rebecca Wenling Zeng, Caitlyn Tan, Gabriel Hong Zhe Wong, Margaret Li Peng Teng et al. · 2023 · Hepatology Communications
High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases
Douglas Ian Walker, Brian D. Juran, Angela Cheung, Erik M. Schlicht, Yongliang Liang, Megan M. Niedzwiecki, Nicholas F. LaRusso, Gregory James Gores, Dean P. Jones, Gary Wright Miller et al. · 2021 · Hepatology Communications
Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study
Min Seo Kim, Minku Song, Soyeon Kim, Beomsu Kim, Wonseok Kang, Jong Yeob Kim, Woojae Myung, Inhyeok Lee, Ron Do, Amit V. Khera et al. · 2023 · Obesity
The Role of Vitamin K in Cholestatic Liver Disease
Halima Sultana, Michio Komai, Hitoshi Shirakawa · 2021 · Nutrients
Additional fibrate treatment in UDCA‐refractory PBC patients
Sung Won Chung, Jeong‐Hoon Lee, Minseok Albert Kim, Galam Leem, Sun Woong Kim, Young Woon Chang, Hyo Young Lee, Jun Sik Yoon, Jun Yong Park, Yun Bin Lee et al. · 2019 · Liver International
Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis
Huang, Chunyang, Han, Weijia, Wang, Chuanmin, Liu, Yanmin, Chen, Yue, Duan, Zhongping · 2019 · Disease Markers
Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis
K. Kowdley, C. Bowlus, C. Levy, M. Mayo, D. Pratt, R. Vuppalanchi, Z. Younossi · 2022 · American Journal of Gastroenterology
New Therapies on the Horizon for Primary Biliary Cholangitis
Atsushi Tanaka · 2023 · Drugs
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Hirschfield, Gideon M, Bowlus, Christopher L, Jones, David E J, Kremer, Andreas E, Mayo, Marlyn J, Tanaka, Atsushi, Andreone, Pietro, Jia, Jidong, Jin, Qinglong, Macías-Rodríguez, Ricardo U et al. · 2026 · The Lancet Gastroenterology & Hepatology
Increased p16INK4a-expressing senescent bile ductular cells are associated with inadequate response to ursodeoxycholic acid in primary biliary cholangitis
Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma · 2019 · Journal of Autoimmunity
Nutrition as Therapy in Liver Disease.
N. Shah, A. Barritt · 2022 · Clinical Therapeutics
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis
Benedikt Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael A Trauner, Thomas Reiberger · 2024 · Alimentary Pharmacology & Therapeutics
Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review
Helen T. Smith, Andréa Ribeiro de Souza, April H. Thompson, Megan McLaughlin, John J. Dever, Julie A. Myers, Jing Voon Chen · 2023 · Digestive Diseases and Sciences
New treatments/targets for primary biliary cholangitis
Christophe Corpechot, Raoul Y. Poupon, Olivier Chazouillères · 2019 · JHEP Reports
The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC
Huiyong Jiang, Ying Yu, Xiaoxiang Hu, Bingbing Du, Yini Shao, Feiyu Wang, Lifeng Chen, Ren Yan, Lanjuan Li, Longxian Lv · 2024 · Gut Microbes
Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease
Feipeng Xu, Hua Zhang, Jiamei Chen, Junyi Zhan, Ping Liu, Wei Liu, Shenglan Qi, Yongping Mu · 2023 · Journal of Ethnopharmacology
Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia
Adrian M. Di Bisceglie, Gerald Francis Watts, Philip T. Lavin, Meng Yu, Ru Bai, Liping Liu · 2020 · Lipids in Health and Disease
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Han Ah Lee, Young Woon Chang, Pil Soo Sung, Eileen Laureal Yoon, Hye Won Lee, Jeong‐Ju Yoo, Young‐Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho et al. · 2022 · Clinical and Molecular Hepatology
The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities
Marta Mazzetti, Giulia Marconi, Martina Mancinelli, A. Benedetti, Marco Marzioni, Luca Maroni · 2021 · Journal of Clinical Medicine
Emerging therapies for PBC
David M. H. Chascsa, Keith D. Lindor · 2020 · Journal of Gastroenterology
Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges
Hirsh D. Trivedi, Christopher J. Danford, Daniela Goyes, Alan Bonder · 2020 · Clinical and Experimental Gastroenterology
Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota–Bile Acid–Immunity Network
Ziqi Guo, Kun He, Ke Pang, Daiyu Yang, Chengzhen Lyu, Haifeng Xu, Dong Wu · 2024 · International Journal of Molecular Sciences
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis
Diletta Overi, Guido Carpino, Laura Cristoferi, Paolo Onori, Lindsey Leann Kennedy, Heather Francis, Nicola Zucchini, Cristina Rigamonti, Mauro Viganò, Annarosa Floreani et al. · 2022 · JHEP Reports
Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis – a case series
Mirjam Kolev, Adela-Cristina Sarbu, Burkhard Möller, Britta Maurer, Florian Kollert, Nasser Semmo · 2023 · Journal of Translational Autoimmunity
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
Hong You, Weijia Duan, Shuxiang Li, Tingting Lv, Sha Chen, Lungen Lu, Xiong Ma, Ying Han, Yuemin Nan, Xiaoyuan Xu et al. · 2023 · Journal of Clinical and Translational Hepatology
Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody
Lu Zhang, Hanbo Yang, Jieping Lei · 2021 · Seminars in Arthritis and Rheumatism
Genetic predisposition of the gastrointestinal microbiome and primary biliary cholangitis: a bi-directional, two-sample Mendelian randomization analysis
Xin Luo, Xin You · 2023 · Frontiers in Endocrinology
Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid
Maria C. van Hooff, E. Werner, A.J. van der Meer · 2024 · European Journal of Internal Medicine
Managing cognitive symptoms and fatigue in cholestatic liver disease
Naw April Phaw, Jessica Leighton, Jessica Katharine Dyson, David E. Jones · 2020 · Expert Review of Gastroenterology & Hepatology
Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
Rozanne C. de Veer, Maren H. Harms, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Harry L.A. Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D. Lindor, Annarosa Floreani et al. · 2022 · Alimentary Pharmacology & Therapeutics
Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis
Jin Sung Jang, Brian D. Juran, Kevin Y. Cunningham, Vinod Kumar Gupta, Young Min Son, Ju Dong Yang, Ahmad Hassan Ali, Elizabeth Ann L. Enninga, Jaeyun Sung, Konstantinos N. Lazaridis · 2020 · Scientific Reports
Primary biliary cholangitis: treatment
Nora Cazzagon, Annarosa Floreani · 2021 · Current Opinion in Gastroenterology
Is liver biopsy still useful in the era of non-invasive tests?
Tae Seop Lim, Ja Kyung Kim · 2020 · Clinical and Molecular Hepatology
Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel
Jennifer Pate, Juilo A Gutierrez, Catherine T Frenette, Aparna Goel, Sonal Rajesh Kumar, Richard A. Manch, Edward Mena, Paul J. Pockros, Sanjaya Kumar Satapathy, Kidist K. Yimam et al. · 2019 · BMJ Open Gastroenterology
Meta-analysis of antinuclear antibodies in the diagnosis of antimitochondrial antibody-negative primary biliary cholangitis
Zhang, Qian, Liu, Zhiqiang, Wu, Shanshan, Duan, Weijia, Chen, Sha, Ou, Xiaojuan, You, Hong, Kong, Yuanyuan, Jia, Jidong · 2019 · Gastroenterology Research and Practice
Hepatocellular Carcinoma in Primary Biliary Cholangitis
Alexander M. Sy, Raphaella Ferreira, Binu V. John · 2022 · Clinics in Liver Disease
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments
Ashley Vander Does, Cynthia Levy, Gil Yosipovitch · 2022 · American Journal of Clinical Dermatology
The role of peroxisome proliferator‐activated receptors in the regulation of bile acid metabolism
Yuqing Sun, Luyong Zhang, Zhenzhou Jiang · 2023 · Basic & Clinical Pharmacology & Toxicology
Adjunct Fenofibrate Up‐regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis
Gallucci, Gina M., Trottier, Jocelyn, Hemme, Christopher, Assis, David N., Boyer, James L., Barbier, Olivier, Ghonem, Nisanne S. · 2021 · Hepatology Communications
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Therapy Landscape
Sheena R. Bhushan, Aalam Sohal, Kris V. Kowdley · 2024 · The American Journal of Gastroenterology
Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
Chunmei Yang, Guanya Guo, Bo Li, Linhua Zheng, Ruiqing Sun, Xiufang Wang, Juan Deng, Gui Jia, Xia Zhou, Lina Cui et al. · 2022 · Hepatology International
A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis
Raj Vuppalanchi, M.S. González-Huezo, Ramon Payan-Olivas, Linda Elsa Muñoz-Espinosa, Farheen Shaikh, Jose L. Pio Cruz-Lopez, Deven Parmar · 2021 · Clinical and Translational Gastroenterology
Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease
Yanyan Li, Na Zhu, Xinyu Cui, Yingying Lin, Xin Li · 2023 · Frontiers in Cellular and Infection Microbiology
Vitamin D Is Associated with Clinical Outcomes in Patients with Primary Biliary Cholangitis
Maryam Ebadi, Stephen Ip, Ellina Lytvyak, Somayyeh Asghari, Elora Rider, Andrew L. Mason, Aldo J. Montaño‐Loza · 2022 · Nutrients
Fine mapping of the MHC region identifies major independent variants associated with Han Chinese primary biliary cholangitis
Chan Wang, Xiaodong Zheng, Ruqi Tang, Chongxu Han, Yuzhang Jiang, Jian Hui Wu, Youlin Shao, Yueqiu Gao, Jianjiang Yu, Zhigang Hu et al. · 2019 · Journal of Autoimmunity
Autoimmune diseases refractory to corticosteroids and immunosuppressants
Zeev Elkoshi · 2024 · Frontiers in Immunology
Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis
Stuart C. Gordon, Kuan-Han Wu, Keith D. Lindor, Christopher L. Bowlus, Carla V. Rodriguez, Heather Anderson, Joseph A. Boscarino, Sheri Trudeau, Loralee B. Rupp, Irina V. Haller et al. · 2020 · The American Journal of Gastroenterology
Role of albumin-bilirubin score in non-malignant liver disease
Shi-Xue Xu, Fan Yang, Nan Ge, Jin Tao Guo, Siyu Sun · 2024 · World Journal of Gastroenterology
Current Landscape and Evolving Therapies for Primary Biliary Cholangitis
Stefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, Michele Biagioli, Eleonora Distrutti · 2024 · Cells
Low rate of new‐onset primary biliary cholangitis in a cohort of anti‐mitochondrial antibody‐positive subjects over six years of follow‐up
Stephan Zandanell, Michael Straßer, Alexandra Feldman, Julia Tevini, Georg Strebinger, David Niederseer, G. Pohla‐Gubo, Ursula Huber-Schönauer, S. Ruhaltinger, Bernhard Paulweber et al. · 2019 · Journal of Internal Medicine
Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid
Dawei Ding, Guanya Guo, Yansheng Liu, Linhua Zheng, Gui Jia, Juan Deng, Ruiqing Sun, Xiufang Wang, Changcun Guo, Yulong Shang et al. · 2022 · Hepatology Communications
Real-World Clinical Management of Patients with Primary Biliary Cholangitis—A Retrospective Multicenter Study from Germany
Anne‐Christin Beatrice Wilde, Charlotte Lieb, E Leicht, Lena Maria Greverath, Lara Marleen Steinhagen, Nina Wald de Chamorro, Jörg Petersen, Wolf Peter Hofmann, Holger M. Hinrichsen, Renate Heyne et al. · 2021 · Journal of Clinical Medicine
Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis
Ruiling Chen, Ruqi Tang, Xiong Ma, M. Eric Gershwin · 2022 · Clinics in Liver Disease
The Emerging Role of Mitochondrial Dysfunction in the Pathogenesis of Idiopathic Inflammatory Myopathies
Jorge A. González-Chapa, Marina Barguil Macêdo, Christian Lood · 2023 · Rambam Maimonides Medical Journal
Main factors influencing long-term outcomes of liver transplantation in 2022
Elisa Fuochi, Lorenzo Anastasio, Erica Nicola Lynch, Claudia Campani, Gabriele Dragoni, Stefano Milani, Andrea Galli, Tommaso Innocenti · 2023 · World Journal of Hepatology
Shear wave elastography and shear wave dispersion imaging in primary biliary cholangitis—a pilot study
Marten Schulz, Anne‐Christin Beatrice Wilde, Münevver Demir, Tobias Müller, Frank Tacke, Alexander Wree · 2021 · Quantitative Imaging in Medicine and Surgery
Rates of decompensation, hepatocellular carcinoma and mortality in AMA‐negative primary biliary cholangitis cirrhosis
Binu V. John, Bassam A Dahman, Yangyang Deng, Nidah Shabbir Khakoo, Tamar Hamosh Taddei, David Edward Kaplan, Cynthia Levy · 2021 · Liver International
Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis
Alicja Bauer, Andrzej Habior · 2022 · Frontiers in Immunology
Pruritus in primary biliary cholangitis is under-recorded in patient medical records
Usha Gungabissoon, Helen T. Smith, Robyn von Maltzahn, John Logie, Jolyon Fairburn-Beech, Liyuan Ma, P Dhirishiya, Ashleigh A. McGirr, Jacob N. Hunnicutt, Christopher L. Rowe et al. · 2024 · BMJ Open Gastroenterology
The albumin–bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC
Takanori Ito, Masatoshi Ishigami, Hikaru Morooka, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Daisaku Nishimura, Toshifumi Tada, Satoshi Yasuda et al. · 2020 · Scientific Reports
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
Jones, David E.J., Wetten, Aaron, Barron-Millar, Ben, Ogle, Laura, Mells, George, Flack, Steven, Sandford, Richard, Kirby, John, Palmer, Jeremy, Brotherston, Sophie et al. · 2022 · eBioMedicine
Beyond the Liver Function Tests: A Radiologist's Guide to the Liver Blood Tests
Brandon M. Metra, Flavius F. Guglielmo, Dina L. Halegoua-DeMarzio, Jesse M. Civan, Donald G. Mitchell · 2021 · Radiographics
Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus
Atsushi Tanaka, Hajime Kono, Patrick S.C. Leung, Merrill Eric Gershwin · 2019 · Cellular Immunology
Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis
Sofía Lachiondo‐Ortega, María Mercado-Gómez, Marina Serrano‐Maciá, Fernando Lopitz‐Otsoa, TANYA B. SALAS-VILLALOBOS, Marta Varela‐Rey, Teresa C. Delgado, Maria Luz Martínez‐Chantar · 2019 · Cells
Liver Transplantation for Primary Biliary Cholangitis
Eric F. Martin · 2022 · Clinics in Liver Disease
Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis
Nidah Shabbir Khakoo, Shahnaz Sultan, John M. Reynolds, Cynthia Levy · 2022 · Digestive Diseases and Sciences
Global Epidemiology of Primary Biliary Cholangitis: An Updated Systematic Review and Meta-Analysis
Jarell Jie-Rae Tan, Ambrose Hon-Lam Chung, Jing Hong Loo, Joo Wei Ethan Quek, Sagar Sharma, Corrine Lee Singh, Roe Xin Jacqueline Yap, Wei Xuan Tay, Matthew K. Smith, Ellina Lytvyak et al. · 2025 · Clinical Gastroenterology and Hepatology
Widespread gaps in the quality of care for primary biliary cholangitis in UK
Mathuri Sivakumar, Akash Gandhi, Eathar Shakweh, Yu Meng Li, Niloufar Safinia, Belinda C. Smith, Aileen Marshall, Lucy Turner, Ashis Mukhopadhya, Hasan Haboubi et al. · 2021 · Frontline Gastroenterology
Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary Cholangitis
Kazuko Ueno, Yoshihiro Aiba, Yuki Hitomi, Shinji Shimoda, Hitomi Nakamura, Olivier Gervais, Yosuke Kawai, Minae Kawashima, Nao Nishida, Seik-Soon Kohn et al. · 2020 · Hepatology Communications
Shear wave-based sound touch elastography in liver fibrosis assessment for patients with autoimmune liver diseases
Lulu Yang, Wenwu Ling, Du He · 2021 · Quantitative Imaging in Medicine and Surgery
Diagnostic value of anti-mitochondrial antibody in patients with primary biliary cholangitis: A systemic review and meta-analysis
Qingling Xu, Weijia Zhu, Yufeng Yin · 2023 · Medicine
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies
Alessio Gerussi, Daphne D’Amato, Laura Cristoferi, Sarah Elizabeth O’Donnell, Marco Carbone, Pietro Invernizzi · 2019 · Annals of Hepatology
Disease burden of primary biliary cholangitis and associated pruritus based on a cross-sectional US claims analysis
Gungabissoon, Usha, Gibbons, Daniel C, Requena, Gema, Ribeiro de Souza, Andrea, Smith, Helen · 2022 · BMJ Open Gastroenterology
Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis
Albert Rodrigo Parés, Mitchell L. Shiffman, Vı́ctor Vargas, Pietro Invernizzi, Elizabeth Smoot Malecha, Alexander Liberman, Leigh MacConell, Gideon Morris Hirschfield · 2020 · Liver International
The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti‐mitochondrial antibodies but without baseline PBC
Weijia Duan, Sha Chen, Shuxiang Li, Tingting Lv, Buer Li, Xiaomin Wang, Yu Wang, Xinyan Zhao, Hong Ma, Xiaojuan Ou et al. · 2022 · Hepatology Communications
Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary Cholangitis
Linhua Zheng, Siyuan Tian, Chunmei Yang, Bo Li, Gui Jia, Yansheng Liu, Ruiqing Sun, Xiufang Wang, Juan Deng, Miao Zhang et al. · 2024 · Clinical Gastroenterology and Hepatology
Seladelpar: First Approval
Sheridan M. Hoy · 2024 · Drugs
Efficacy of ursodeoxycholic acid combined with prednisolone and immunosuppressant triple therapy in the treatment of refractory primary biliary cholangitis
T T Yao, Jiandan Qian, Gui-Qiang Wang · 2020 · Medicina Clínica
The evolving role of liver biopsy: Current applications and future prospects
Purva Gopal, Xiaobang Hu, Marie E. Robert, Xuchen Zhang · 2025 · Hepatology Communications
Ursodeoxycholic acid impairs liver‐infiltrating T‐cell chemotaxis through IFN‐γ and CX3CL1 production in primary biliary cholangitis
Shin Shimoyama, Kazuhito Kawata, Kazuyoshi Ohta, Takeshi Chida, Tetsuro Suzuki, Koichi Tsuneyama, Shinji Shimoda, Nobuhito Kurono, Patrick S.C. Leung, Merrill Eric Gershwin et al. · 2021 · European Journal of Immunology
We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases
Brian T. Lee, Michele May-Sien Tana, Jeffrey A. Kahn, Lily Dara · 2021 · Hepatology
Emerging novel treatments for autoimmune liver diseases
Atsushi Tanaka · 2019 · Hepatology Research
Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis
Jihyun An, Young Eun Chon, Gunho Kim, Mi Na Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Miyoung Choi, Dae Won Jun, Seung Up Kim et al. · 2024 · Clinical and Molecular Hepatology
Ursodeoxycholic Acid Treatment–Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis
Rozanne C. de Veer, Maria C. van Hooff, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Willem J. Lammers, Harry L.A. Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D. Lindor et al. · 2022 · The American Journal of Gastroenterology
Use of Butorphanol as Treatment for Cholestatic Itch
Rachel Shireen Golpanian, Gil Yosipovitch, Cynthia Levy · 2020 · Digestive Diseases and Sciences
Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis
Surain B. Roberts, Gideon Morris Hirschfield, Lawrence Worobetz et al. · 2022 · Hepatology